Hancock Whitney Corp Rvl Pharmaceuticals PLC Transaction History

Hancock Whitney Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 04, 2021	SELL	$2.79 - $4.19 $149,889 - $225,103	-53,724 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$2.8 - $3.78 $98,714 - $133,263	35,255 Added 190.89%	53,724 $162,000
Q3 2020 Nov 05, 2020	SELL	$4.82 - $8.77 $19,280 - $35,080	-4,000 Reduced 17.8%	18,469 $100,000
Q2 2020 Jul 30, 2020	BUY	$2.83 - $6.99 $63,587 - $157,058	22,469 New	22,469 $151,000
Q2 2019 Aug 29, 2019	SELL	$2.34 - $4.28 $54,063 - $98,885	-23,104 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$3.6 - $8.75 $83,174 - $202,160	23,104 New	23,104 $83,000

92.5K

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

Stay updated on Hancock Whitney Corp with notifications on news.